embecta

Today we hosted our Fourth Quarter Fiscal Year 2025 earnings call. You can read the results in our press release here: bit.ly/4ikXnWp

Join our fourth quarter fiscal year 2025 earnings call tomorrow at 8:00 a.m. ET. Tune in here: investors.embecta.com.

Today we hosted our Third Quarter Fiscal Year 2025 earnings call. You can read the results in our press release here: bit.ly/4m856s3

Join our third quarter fiscal year 2025 earnings call Friday at 8:00AM ET. Tune in here: investors.embecta.com.

We’re excited to host our inaugural Analyst and Investor Day on Thursday, May 22, to showcase our strategic vision and long-range financial plan. Register at investorday.embecta.com.

Today we hosted our Second Quarter Fiscal Year 2025 earnings call. You can read the results in our press release here: bit.ly/4jQ0AgC

Join our Second Quarter Fiscal Year 2025 earnings call tomorrow at 8:00AM ET. Tune in here: investors.embecta.com.

Find your purpose supporting the #diabetes community by driving innovation in the field. Learn more about our open careers here: bit.ly/49AuOzu

Are your patients with #diabetes staying vigilant about #kidneycare? These #WorldKidneyDay reminders can help them keep their kidney health top of mind.

Today we hosted our First Quarter Fiscal Year 2025 earnings call. You can read the results in our press release here: bit.ly/3CIijGl

Join our First Quarter Fiscal Year 2025 earnings call tomorrow at 8:00AM ET. Tune in here: investors.embecta.com.

Earlier today, our President and CEO Dev Kurdikar presented at #JPM2025. Miss the live presentation? Check out his remarks here: bit.ly/4fWJOJJ

Come say hello to us tomorrow at #JPM2025! Our President and CEO Dev Kurdikar will be presenting at 7:30 a.m. PT / 10:30 a.m. ET. Not attending? Listen to the webcast here: bit.ly/4fWJOJJ

Happy New Year 2025!

We're looking forward to presenting at the 43rd annual J.P. Morgan Healthcare Conference. Read more about our participation at #JPM2025 in our release: investors.embecta.com/news-releases/…

We’re proud to partner with @embecta. Our deep expertise in the life sciences & healthcare sectors alongside our capabilities in data and technologies enables embecta’s vision to make a meaningful impact in the healthcare sector. bit.ly/4fsSLf5

Lunch is absorbing and insulin is flowing as #DiabetesMine founder Amy Tenderich gives the opening presentation to kick off #DData2024 Many thanks to the sponsors: @dexcom @EliLillyandCo @myomnipod @embecta and @MannKindCorp

Join our second quarter fiscal year 2024 earnings call tomorrow at 8:00AM ET. Tune in here: investors.embecta.com.

Today is the day! We're excited to start #ATTD2024 with our Industry Symposium. Join us for insights into exciting #diabetes technology research. Elevate your diabetes care knowledge with us today!

Tomorrow, these distinguished faculty will present new research on the potential of #insulin pump therapy for #T2D and the future of personalized #diabetes care at our #ATTD2024 Industry Symposium. Hope to see you there!